ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
two
|
164 |
45K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
7 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
13K
|
5.5M
|
7
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Australia Limited - CEO Termination
|
|
two
|
90 |
53K |
1 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
90
|
53K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
Capital Raising or other?
|
|
two
|
4 |
3.2K |
1 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
4
|
3.2K
|
1
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Australia Limited - CEO Termination
|
|
two
|
90 |
53K |
2 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
90
|
53K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
two
|
75 |
27K |
4 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
75
|
27K
|
4
|
|
ASX - By Stock
|
AHF |
Re:
News: AHF Australian Dairy Nutritionals Says It's Infant Formula Facility Obtains Export...
|
|
two
|
91 |
18K |
2 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
91
|
18K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
2023
|
|
two
|
184 |
88K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
184
|
88K
|
1
|
|
ASX - By Stock
|
AHF |
Re:
Ann: AHF's Infant Formula Facility Obtains Export Certification
|
|
two
|
27 |
4.9K |
1 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
27
|
4.9K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
2023
|
|
two
|
184 |
88K |
3 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
184
|
88K
|
3
|
|
ASX - By Stock
|
NVX |
Re:
2023
|
|
two
|
184 |
88K |
1 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
184
|
88K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
2023
|
|
two
|
184 |
88K |
2 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
184
|
88K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
two
|
75 |
33K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
75
|
33K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
Ann: NOVONIX Change of Financial Year to 31 December
|
|
two
|
3 |
2.0K |
5 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
3
|
2.0K
|
5
|
|
ASX - By Stock
|
NVX |
Re:
Ann: NVX Provides Update on Synthetic Anode Materials Production
|
|
two
|
139 |
60K |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
139
|
60K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
NVX Fundamental Analysis - a multi MULTI bagger
|
|
two
|
356 |
230K |
2 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
356
|
230K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
NVX Fundamental Analysis - a multi MULTI bagger
|
|
two
|
356 |
230K |
1 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
356
|
230K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
NVX Fundamental Analysis - a multi MULTI bagger
|
|
two
|
356 |
230K |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
356
|
230K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
NVX Fundamental Analysis - a multi MULTI bagger
|
|
two
|
356 |
230K |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
356
|
230K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
10 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
13K
|
5.5M
|
10
|
|
ASX - By Stock
|
NVX Graphite |
Re:
NVX Chart
|
|
two
|
4.1K |
2.0M |
12 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
4.1K
|
2.0M
|
12
|
|
ASX - By Stock
|
AHF |
Re:
Ann: Results of EGM
|
|
two
|
21 |
6.2K |
2 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
21
|
6.2K
|
2
|
|
ASX - By Stock
|
AHF |
Re:
Ann: Results of EGM
|
|
two
|
21 |
6.2K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
21
|
6.2K
|
3
|
|
ASX - By Stock
|
AHF |
Re:
Ann: Results of EGM
|
|
two
|
21 |
6.2K |
2 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
21
|
6.2K
|
2
|
|
ASX - By Stock
|
AHF |
Re:
Ann: Results of EGM
|
|
two
|
21 |
6.2K |
1 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
21
|
6.2K
|
1
|
|
ASX - By Stock
|
AHF |
Re:
Ann: Results of EGM
|
|
two
|
21 |
6.2K |
3 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
21
|
6.2K
|
3
|
|
ASX - By Stock
|
AHF |
Re:
Ann: How to Vote at the EGM
|
|
two
|
8 |
3.0K |
5 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
8
|
3.0K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Presentation
|
|
two
|
45 |
16K |
13 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
45
|
16K
|
13
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
9 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
13K
|
5.5M
|
9
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
8 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
13K
|
5.5M
|
8
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
13K
|
5.5M
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Pause in Trading
|
|
two
|
19 |
5.0K |
4 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
19
|
5.0K
|
4
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Response to ASX Query
|
|
two
|
51 |
16K |
0 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
51
|
16K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
Ann: NVX SELECTED FOR US$150 MILLION GRANT FROM US DEPT OF ENERGY
|
|
two
|
148 |
71K |
8 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
148
|
71K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
two
|
81 |
28K |
3 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
81
|
28K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
two
|
81 |
28K |
1 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
81
|
28K
|
1
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
4 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
13K
|
5.5M
|
4
|
|
ASX - By Stock
|
BFC |
Re:
Tax Losses
|
|
two
|
15 |
6.9K |
3 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
15
|
6.9K
|
3
|
|
ASX - By Stock
|
AHF |
Re:
Ann: CEO Letter - AHF's Transformation Journey
|
|
two
|
1 |
764 |
3 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
1
|
764
|
3
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Strategic Investment In Leading Gut Health Biotech Ateria Health
|
|
two
|
5 |
2.4K |
1 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
5
|
2.4K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
two
|
37 |
12K |
14 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
37
|
12K
|
14
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
2 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
13K
|
5.5M
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
two
|
1.6K |
465K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
1.6K
|
465K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
5.5M
|
1
|
|
ASX - By Stock
|
NVX |
Re:
Media Watch - NVX related
|
|
two
|
13K |
5.5M |
5 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
5.5M
|
5
|
|
Charts
|
BUB |
Re:
BUB chart
|
|
two
|
2.9K |
1.5M |
1 |
21/07/22 |
21/07/22 |
Charts
|
2.9K
|
1.5M
|
1
|
|
Charts
|
BUB |
Re:
BUB chart
|
|
two
|
2.9K |
1.5M |
2 |
21/07/22 |
21/07/22 |
Charts
|
2.9K
|
1.5M
|
2
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Trading Halt
|
|
two
|
96 |
52K |
0 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
96
|
52K
|
0
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Trading Halt
|
|
two
|
96 |
52K |
8 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
96
|
52K
|
8
|
|
ASX - By Stock
|
NVX |
Re:
Ann: NOVONIX TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
|
|
two
|
47 |
19K |
3 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
47
|
19K
|
3
|
|